Á lódáil...

Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Blood
Main Authors: Cheah, Chan Yoon, Nastoupil, Loretta J., Neelapu, Sattva S., Forbes, Sheryl G., Oki, Yasuhiro, Fowler, Nathan H.
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Hematology 2015
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161005/
https://ncbi.nlm.nih.gov/pubmed/25999447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-633156
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!